Initiating stiripentol before 2 years of age in patients with Dravet syndrome is safe and beneficial against status epilepticus

Chiron et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69d7609d5f9a1dad5348ffd7 — DOI: https://doi.org/10.1111/dmcn.15638

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. A definition and classification of status epilepticus – Report of the <scp>ILAE</scp> Task Force on Classification of Status Epilepticus· 2015 · 2,328 citations
2. Stiripentol in refractory status epilepticus· 2013 · 22 citations
3. From Raw Data to FAIR Data: The FAIRification Workflow for Health Research· 2020 · 123 citations
4. The core Dravet syndrome phenotype· 2011 · 617 citations
5. Mortality in Dravet syndrome· 2016 · 310 citations